Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Document › Details

Malvern Instruments Ltd.. (9/30/13). "Press Release: Malvern Instruments Acquires Nanoparticle Characterization Company NanoSight".

Organisations Organisation Malvern Instruments Ltd.
  Group Spectris (Group)
  Organisation 2 NanoSight Ltd.
  Group Spectris (Group)
Products Product Nanoparticle Tracking Analysis technology (NTA technology)
  Product 2 Zetasizer
Index term Index term NanoSight–Spectris: investment, 201309 acquisition of NanoSight Ltd by Malvern Instruments Ltd
Persons Person Walker, Paul (Spectris 201309 Managing Director of Malvern Instruments Ltd)
  Person 2 Warren, Jeremy (NanoSight Ltd 201309 CEO)
     


Malvern Instruments Ltd (Malvern, UK), a leading global provider of instrumentation and expertise for materials and biophysical characterization, has acquired nanoparticle characterization company NanoSight Ltd (Amesbury, UK). The acquisition was completed on 30th September 2013.

NanoSight has developed and commercialized a unique and patented technology, Nanoparticle Tracking Analysis (NTA). The company's instrumentation and software enable the rapid and simultaneous multi-parameter analysis and characterization of many different types of nanoscale particles. With their ability to analyze particle size, concentration, zeta potential and aggregation, NanoSight systems are closely aligned with Malvern's market-leading Zetasizer range, extending Malvern's solutions for those working at the nanoscale.

Currently the largest applications area for NTA is in life sciences, for the measurement of biological nanoparticles, where one of the most exciting and rapidly expanding fields is exosomes. These are intercellular messengers whose quantity and biochemical composition reflect the disease status of an individual. NanoSight technology uniquely provides quantitative detection and characterization capabilities to make exosomes a viable proposition as biomarkers for drug discovery, disease prognosis, diagnosis and monitoring, as well as personalized medicine.

Paul Walker, Managing Director of Malvern Instruments, said: "NanoSight is a real entrepreneurial success story and I am delighted to be welcoming the NanoSight team to Malvern. NanoSight has grown every year since it was established in 2002 and has ambitious plans for the future. We will be providing the investment and support needed to continue this drive forward and are absolutely committed to developing the NanoSight brand within the Malvern portfolio.

"NanoSight's unique technology has become accepted in laboratories around the world and is widely cited in research publications. With rapid advances in nanomaterials and the life sciences, in biopharmaceuticals especially, the demand for new technologies to answer continually evolving analytical challenges has never been greater. This is a very exciting time and by bringing together complementary, leading edge technologies, Malvern continues to focus on delivering the analytical tools which laboratories so urgently need."

Jeremy Warren, CEO of NanoSight, said, "We have always seen Malvern as clear leader in our sector, and the exemplar of what we wish to become. The plans we have are ambitious and exciting, and the support and reach of the Malvern organization will allow us to grow more rapidly than we could alone. I am sure that this change will bring opportunity to both our business and our colleagues. Malvern is our natural home."

NanoSight employs around 50 people worldwide and will continue to operate from its current facilities in Amesbury, Wiltshire, UK, under the existing management team. Malvern's direct sales operations in key geographies and wider global presence will be used to make the NanoSight instruments and aftersales support even more accessible to a wider market.

For further details about NanoSight products go to http://www.nanosight.com/products
To find out more about Malvern visit www.malvern.com

Malvern and Malvern Instruments are registered trademarks of Malvern Instruments Ltd


For more information on this press release, contact:

For media information please contact:

Trish Appleton
Kapler Communications Limited
Phoenix House,
Phoenix Park,
Eaton Socon,
Cambridgeshire,
PE19 8EP, UK

Tel: +44 (0)1480 471059
Fax: +44 (0)1480 471069
trish.appleton@kapleronline.com
Please send sales enquiries to:

Alison Vines
Malvern Instruments Ltd
Enigma Business Park
Grovewood Road
Malvern
Worcestershire
WR14 1XZ, UK

Tel: +44 (0) 1684 892456
Fax: +44 (0) 1684 892789
alison.vines@malvern.com

   
Record changed: 2016-01-10

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Spectris (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top